Search

Intuitive Surgical Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

367.94 -1.56

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

353.86

Max

375.77

Pagrindiniai rodikliai

By Trading Economics

Pajamos

1.7M

823M

Pardavimai

122M

2.9B

P/E

Sektoriaus vid.

38.744

64.641

Pelnas, tenkantis vienai akcijai

2.37

Pelno marža

28.462

Darbuotojai

17,021

EBITDA

34M

1.2B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+29.87% upside

Dividendai

By Acuity

Kitas uždarbis

2026-10-20

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-16B

128B

Ankstesnė atidarymo kaina

369.5

Ankstesnė uždarymo kaina

367.94

Naujienos nuotaikos

By Acuity

64%

36%

286 / 340 reitingas Healthcare

Intuitive Surgical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-03 20:03; UTC

Correlated Moves
News

Intuitive Surgical Inc shares are higher as the company reports a 19% revenue increase to $2.89 billion and reaffirms full-year guidance.

2026-07-31 23:41; UTC

Intuitive Surgical shares are higher in after-market hours, despite a broader market decline and trading near the lower end of its one-month range.

2026-07-30 20:09; UTC

Intuitive Surgical Inc. shares are near unchanged amid broader market volatility and disappointing economic data, including lower-than-expected GDP growth and rising jobless claims.

2026-07-29 23:21; UTC

Intuitive Surgical Inc. shares declined in after-market trading, reflecting ongoing weakness and a lack of momentum following an initial peak.

2026-07-28 18:32; UTC

News
Correlated Moves
Social Media

Intuitive Surgical Inc shares rose after UBS initiated coverage with a Buy rating and a $500 price target, reflecting confidence in growth potential.

2026-07-27 20:02; UTC

Social Media
News

Intuitive Surgical partners with Deion Sanders to boost awareness of robotic surgery options. Shares are trading higher amid positive market sentiment.

2026-07-24 17:02; UTC

Social Media
Correlated Moves
News

Intuitive Surgical shares are advancing as The Motley Fool identifies the company as a strong buy, citing solid medium-term prospects despite competitive challenges.

2026-07-23 20:03; UTC

News

Intuitive Surgical shares are lower today after a significant early drop, continuing a trend of three consecutive daily declines despite an AI-focused presentation at a conference.

2026-07-22 18:52; UTC

News

Intuitive Surgical shares lower as Johnson & Johnson gains FDA authorization for its Ottava Surgical Robot, raising competitive concerns in robotic surgery.

2026-07-21 19:42; UTC

News

Intuitive Surgical Inc shares are lower as analysts express caution amid rising GLP-1 medication use and the expiration of ACA enhanced premiums.

2026-07-20 19:41; UTC

Social Media
News

Intuitive Surgical's price target lowered to $685 by Bernstein, yet shares are higher today amid a recovery and new extended use program launch.

2026-07-17 19:41; UTC

News
Social Media

Intuitive Surgical shares are lower after analysts cut price targets, with Mizuho lowering its target to $400 amid concerns over slowing procedure trends.

2026-07-16 23:02; UTC

News
Social Media

Intuitive Surgical shares fell in after-market trading despite strong earnings, as management cited U.S. market challenges and a Class II recall of surgical components.

2026-07-15 19:52; UTC

News

Intuitive Surgical reports first-quarter revenue of $2.77 billion, up from $2.25 billion last year. Shares are advancing despite a recent product recall.

2026-07-14 20:02; UTC

Correlated Moves
News

Intuitive Surgical shares are lower as Baird cuts price target to $525 from $610. The stock has reached a 25-month low at $395.02.

2026-07-13 23:11; UTC

Intuitive Surgical shares traded roughly flat in after-hours trading, showing little momentum amid broader market pressure on major tech stocks.

2026-07-10 20:06; UTC

Event

Intuitive Surgical Inc shares are lower as investors await Q2 earnings, with analysts estimating EPS of $2.41 and revenue of $2.8 billion.

2026-07-09 19:51; UTC

News
Correlated Moves

Intuitive Surgical shares are lower despite BMO Capital's Outperform rating and $518 target. The stock has declined for three consecutive sessions since Wednesday.

2026-07-08 19:51; UTC

Social Media

Intuitive Surgical Inc shares are lower today amid a decline in the Health Care Equipment sub-sector. Citi placed the company on its upside catalyst watch.

2026-07-07 19:44; UTC

News

Intuitive Surgical Inc is down today, reversing from earlier gains amid notable volatility. The company continues to benefit from strong market positioning in robotic-assisted surgery.

2026-07-06 23:46; UTC

Intuitive Surgical shares are higher in after-market trading, continuing an upward trend from the previous three sessions. No specific news was identified for the move.

2026-07-02 23:16; UTC

Intuitive Surgical shares declined in after-market trading, reflecting routine performance amid broader market sentiment influenced by lower-than-expected job growth.

2026-07-01 23:56; UTC

Intuitive Surgical Inc. shares are trading roughly flat in after-market hours, reflecting routine performance amid a slight decline from its 20-day moving average.

2026-06-30 20:01; UTC

News
Correlated Moves

Intuitive Surgical shares are lower, reaching a four-week low amid declines in the Health Care Equipment sub-sector and volatility in the market.

2026-06-29 19:56; UTC

News

Intuitive Surgical reports strong growth in da Vinci system installations, with shares higher since Friday's close, despite pulling back from earlier session highs.

2026-06-26 23:16; UTC

Intuitive Surgical Inc shares are higher in after-market trading, though they remain below their 20-day moving average amid broader economic signals and inflation concerns.

2026-06-25 19:56; UTC

Intuitive Surgical Inc's shares are lower, reflecting a broader trend and trading below the 20-day moving average amid mixed economic indicators impacting the health care sector.

2026-06-24 23:36; UTC

Intuitive Surgical shares declined in after-market trading, reflecting mixed global market performance amid geopolitical tensions. The stock is below its 20-day moving average.

2026-06-23 19:16; UTC

Intuitive Surgical Inc. shares are declining, trading near the lower end of their one-month range amid broader equity market declines across Asia.

2026-06-22 23:26; UTC

Intuitive Surgical Inc. shares declined in after-market trading, nearing the lower end of their one-month range, despite earlier recovery attempts.

Akcijų palyginimas

Kainos pokytis

Intuitive Surgical Inc Prognozė

Kainos tikslas

By TipRanks

29.87% į viršų

12 mėnesių prognozė

Vidutinis 487.55 USD  29.87%

Aukščiausias 685 USD

Žemiausias 366 USD

Remiantis 24 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Intuitive Surgical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

24 ratings

19

Pirkti

4

Laikyti

1

Parduoti

Rinkos nuotaikos

By Acuity

286 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat